FIELD: pharmacy. SUBSTANCE: invention relates to the use of the known bioactive substance (analgetic) flupirtin as an agent decreasing muscle rigidity, in part, for Parkinson's disease treatment in combination with (-)-deprenil or bipyridine, or L-DOPA at ratio of components = (1:0.01)-(1: 1). Agent does not show central by-side effects (ataxia or decrease of spontaneous motoric activity). EFFECT: enhanced effectiveness of agent proposed. 1 tbl
Authors
Dates
1996-12-20—Published
1991-07-12—Filed